Navigation Links
The Feinstein to collaborate with Sweden's Karolinska Institute
Date:4/9/2008

MANHASSET, NY As part of its global mission of advancing science, The Feinstein Institute for Medical Research announced today that it has signed a collaborative agreement with the renowned Karolinska Institutet in Sweden. The agreement paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from The Feinstein to study at the Karolinskas laboratories in Stockholm.

The Karolinska Institutet is always looking for outstanding training environments for their graduates, said Kevin J. Tracey, MD, director and chief executive of The Feinstein. And we want the students of our Elmezzi Graduate School of Molecular Medicine to have a challenging post-doctoral career as well. It couldnt be a better fit.

According to the agreement, both institutes have established joint programs to enhance the training and research of each institutes students and post-doctoral researchers. The collaboration will mean that as many as half a dozen scientists may be able to study abroad and that Feinstein scientists can host an equal number of Karolinskas post-doctoral students. They will still have to apply for a seat in the lab in New York or abroad, and a joint admissions committee from both institutes will review the applications and make the selections.

Our mission is translational research, and we offer a progressive basic and clinical training environment, added Dr. Tracey, an immunologist who collaborated with Karolinskas Jan Andersson, M.D., the head of infectious diseases, studying cytokines and inflammation. Dr. Andersson was also the first invited lecturer for The Feinstein Institutes Marsh lecture in 2005. His research includes the study of the potential role of regulatory T-cells in HIV/AIDS. He has discovered that HIV infection is associated with an increase of regulatory T-cells that negatively affect the capacity to mount a fully functional CD8 T-cell response against the infection. These regulatory T-cells could become a target for future treatments to reconstitute the immune system damaged by HIV infection.

The graduate students at the Karolinska and The Feinstein are medical doctors who have gone on to obtain a doctoral degree in research. The faculty leadership is always looking for the best and brightest post-doctoral students, said Dr. Tracey. These students are the heart of the lab.


'/>"/>

Contact: Jamie Talan
jtalan@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related medicine news :

1. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
2. The Wistar Institute collaborates with the Coriell Institute to distribute cell lines
3. INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement
4. AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards
5. The National ePrescribing Patient Safety Initiative Collaborates With Google
6. Quest Diagnostics to Collaborate with Google on New Health Offering
7. Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
8. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
9. Cleveland Clinic Collaborates with Google
10. BayCare Health System Collaborates With Accenx to Provide Reliable Exchange of Information
11. Geisinger and Celera to collaborate on liver disease test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... NucleusHealth ™, advancing clinical ... U.S. Food and Drug Administration (FDA) 510(k) clearance for its ... platform for medical image management. At the core is patented streaming technology that ...
(Date:5/24/2017)... Cortland, OH (PRWEB) , ... May 24, 2017 , ... ... in Cortland, OH, can now meet with Dr. Joseph Bedich for a consultation, ... smiles while simultaneously improving their oral health and functionality. , Dr. Bedich ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Curry Leavitt, a noted ... Periodontal Practice) continuing education (CE) series. As a compassionate and dedicated clinician, Dr. ... attending numerous CE courses each year. His recent course, Course II of HP3, ...
(Date:5/24/2017)... ... May 24, 2017 , ... Accordant ... its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with machine learning, that ... from the datacenter to the cloud to the edge. Through the new partnership, ...
(Date:5/24/2017)... ... 2017 , ... Rob Lowe is a sought after actor, and also serves ... the public important topics from all aspects of life, and a new segment is ... feet and ankles. , Podiatry is essential to people’s overall well-being, and if viewers ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 Radiology has become the number ... have also spiraled to the number one ranking as ... than ever before as the most complete and reliable ... with lower back pain an MRI may confirm a ... pain, resulting in entirely different treatment protocols.  In these ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
Breaking Medicine Technology: